New Delhi : The Delhi High Court has barred the export of generic kidney and liver cancer medication, Sorefenat, manufactured by Natco Pharma Ltd on the plea of German drug major Bayer Corporation.
Justice Manmohan, however, gave liberty to Natco to seek the court’s permission to export the drug as and when it gets the nod from the Drug Controlling Authority.
The court also issued notice to the Centre, customs authorities and Natco, seeking their replies on the plea of Bayer which has alleged that the generic drug is being made under compulsory licence for sale in India and thus, it cannot be exported.
Bayer has sought directions to the customs authorities to seize and confiscate the consignment.
Union Ministers Suresh Gopi And George Kurian Welcome Kerala’s Delayed Move To Join PM SHRI Scheme
Kerala Education Minister V. Sivankutty Meets CPI Leaders To Ease Tensions Over PM SHRI Schools MoU
Jharkhand CEO Reviews Special Intensive Revision Preparations, Voter Mapping Progresses Rapidly
CSIR UGC NET December 2025: NTA Announces Revised Registration And Fee Dates; Check Details
